The comparison of methods to assess in vitro drug release from nanoparticles
Ahlin Grabnar, Pegi (Author), Kerč, Janez (Author), Homar, Miha (Author), Kristl, Julijana (Author)

URLURL - Presentation file, Visit http://www.scipharm.at/download.asp?id=829 This link opens in a new window

In studying in vitro drug release from nanoparticles (NPs) an important issue to consider is the method that can be used to measure drug release [1]. The characterization of the in vitro drug release from a colloidal carrier is technically difficult to achive. This can be attributed to the inability of effective and rapid separation of the particles from the dissolved or released drug in the surrounding medium owing to the very small size of nanocarriers [2]. The aim of our study was to compare in vitro release profiles of budesonide from NPs, which were obtained using four different methods for the assessment of drug release: membrane diffusion technique (dialysis or reverse dialysis) and sample and separate technique (filtration or ultracentrifugation). Budesonid as a hydrophobic drug was incorporated intopoly(lactic acid) NPs, which were prepared by the nanoprecipitation method using vibrating nozzle device [3]. The mean size of NPs was 260 nm, the entrapment efficiency of budesonid 70 % and drug content 5,6 %. Our results show that in vitro drug release profiles from NPs obtained by four methods were different. In vitro release profiles obtained by filtration, centrifugation and reverse dialysis exhibited a typical biphasic release phenomenon namely initial burst release and consequently sustained release. The critical points in filtration are the pore size and adsorption of dissolved drug on filter membrane. The problem with centrifugation is that smallest particles are very slow to sediment and further dissolution can occurover this time. The fastest burst release phase was obtained after centrifugation following by filtration and reverse dialysis. The release of budesonide from NPs determined by dialysis was much slower and showed no burstrelease. In this method the transport across the membrane was rate limiting, and therefore the true release rate was not measured. No clear agreement exists on the suitability of the techniques reported to date for drug release determination from particles in the nanometer size range. Our results show that the comparison of in vitro release results obtaned by different methods is not reasonable.

Keywords:nanodelci, sproščanje, budesonid
Work type:Not categorized (r6)
Tipology:1.12 - Published Scientific Conference Contribution Abstract
Organization:FFA - Faculty of Pharmacy
Number of pages:Str. 679
ISSN on article:0036-8709
COBISS.SI-ID:2858865 Link is opened in a new window
Average score:(0 votes)
Your score:Voting is allowed only to logged in users.
AddThis uses cookies that require your consent. Edit consent...

Record is a part of a proceedings

Title:Abstracts of the 8th Central European Symposium on Pharmaceutical Technology (CESPT), Satellite Symposium: 4th International Graz Congress on Pharmaceutical Engineering, September 16th-18th, Graz, Austria
COBISS.SI-ID:2845297 This link opens in a new window

Record is a part of a journal

Title:Scientia Pharmaceutica
Shortened title:Sci. Pharm.
Publisher:Oesterreichische Apotheker-Verlagsgesellschat MBH
COBISS.SI-ID:26371584 This link opens in a new window

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:


Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
There are no comments!